(R)-NODAGA-tris(t-Bu ester) is a protected chelating agent intermediate used in bioconjugation. It features a triazacyclononane macrocycle with tert-butyl ester protecting groups and a free carboxylic acid, designed for subsequent activation and conjugation to biomolecules.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1252799-47-5
DOTA-GA(tBu)4
research compound
(Z)-3-(Hydroxyimino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
pharmaceutical intermediate
(2-(3-(Aminomethyl)-5-methyl-4H-1,2,4-triazol-4-yl)-5-chlorophenyl)(phenyl)methanone
pharmaceutical intermediate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanine
pharmaceutical intermediate
(S)-2-Amino-1,1,1-trifluoropropane hydrochloride
pharmaceutical intermediate
(S)-4-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid
research compound
NOTA-bis(tBu)ester
research compound
1,4,7-triazonane
research compound
(4R)-4-[4,7-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7-triazonan-1-yl]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
ADHGPCATMVZKLP-HXUWFJFHSA-N
CC(C)(C)OC(=O)CN1CCN(CCN(CC1)[C@H](CCC(=O)O)C(=O)OC(C)(C)C)CC(=O)OC(C)(C)C